tscan.com (TCRX): Balans kapitallashuviga qarzlar

TScan Therapeutics, Inc. (TCRX) grafik logotipi

Hujayraviy onkologiya muolajalarining ishlab chiqilishi YaIM fazalari yoki mavsumiylikka bog'liq bo'lmay, aksincha, tibbiy yutuqlarga tayanadi. Qarzning bozor kapitalizatsiyasiga nisbati qarz yuklamasini baholash imkonini beradi, bunda 1.32 qiymati asosiy ko'rsatkich vazifasini o'taydi. Sinovlar davomidagi likvidlik sarfi mavjudligiga qaramay, TScan Therapeutics (TCRX) kompaniyasining muvaffaqiyati terapiyaning xavfsizligi va tashqi kapitalning mavjudligi bilan belgilanadi.

TScan Therapeutics Inc (TCRX) - Balans qiymatiga qarzlar 04.07.2022dan 27.10.2026gacha

tscan.com (TCRX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi TScan Therapeutics, Inc.|TCRX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi TCRX|TCRX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati TScan Therapeutics|TCRX - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati tscan.com|TCRX - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati TScan Therapeutics|TCRX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati TScan Therapeutics, Inc.|TCRX - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati TCRX
Kompaniyaning barcha koʻrsatkichlari tahlili:TScan TCRX
tscan.com asosiy tovari

TScan Therapeutics qattiq o'smalarga yo'naltirilgan T-hujayralar terapiyasi uchun yuqori texnologik ekotizimni ishlab chiqmoqda. 1.32 ko'rsatkichi qarz mablag'larining kapitalga nisbatini aks ettirib, biznesning tashqi moliyalashtirishga bog'liqligini belgilaydi. Umumiy qarzdorlikning kitob qiymatidagi kapitalga nisbati tendentsiyasini tahlil qilish orqali investor o'sish sur'atlariga nisbatan defolt xavfini baholaydi. Barqaror grantlar va FDA tartibga soluvchi nazorati ushbu balansni kengayish uchun muhim qiladi. Ushbu ko'rsatkichning past darajasi kompaniyaning fundamental barqarorligini tasdiqlaydi.

TScan Therapeutics kimlar bilan raqobatlashadi

ONC - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati halozyme.com HALO|RVMD: Balans kapitallashuviga qarzlar|AAPG - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CGON|URGN (UroGen Pharma Corp) - Balans qiymatiga qarzlar|BCAX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati personalis.com (PSNL)|Erasca (ERAS) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Delcath Systems Inc (DCTH)|YmAbs - Balans kapitallashuviga qarzlar|AURA - Qarzning balans qiymatiga nisbati|Candel - Qarzning balans qiymatiga nisbati|ARAY: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati sellaslifesciences.com SLS|Actuate Therapeutics Inc. (ACTU) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar CTOR (Citius Oncology, Inc)|Balans qiymatiga qarzlar TuHURA (HURA)|Qarzning balans qiymatiga nisbati Protara Therapeutics|Qarzning balans kapitaliga nisbati FATE (fatetherapeutics.com)|Qarzning balans kapitallashuviga nisbati WHWK|Sof aktivlarga qarzlar Champions Oncology Inc CSBR|XBIT: Balans kapitallashuviga qarzlar|CVM - Qarzning balans qiymatiga nisbati|OSTX: Balans kapitallashuviga qarzlar|RADX (radiopharmtheranostics.com) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Artiva Biotherapeutics Inc. (ARTV)|Qarzning balans qiymatiga nisbati Adlai Nortye Limited (ANL)|Veru Pharma (VERU) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Tempest Therapeutics Corp TPST|Qarzning balans qiymatiga nisbati Xilio Therapeutics (XLO)|Qarzning balans kapitaliga nisbati Renovaro Biosciences RENB|Balans kapitallashuviga qarzlar Mural Bio (MURA)|KAPA - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar OKUR|GDTC (CytoMed Therapeutics Limited) - Balans qiymatiga qarzlar|CRIS - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Apollomics Corp|Balans kapitallashuviga qarzlar THAR|Balans kapitallashuviga qarzlar ADVB (advanbiomed.com)|Genprex, Inc (GNPX) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Calidi Biotherapeutics Inc. CLDI|SBFM (Sunshine Biopharma, Inc.) - Balans kapitallashuviga qarzlar|Xenetic Biosciences (XBIO) - Balans qiymatiga qarzlar|SLRX: Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Purple Biotech Ltd|American Oncology Network Inc (AONC) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati BeiGene Ltd|CKPT (Checkpoint Therapeutics) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar elevationoncology.com (ELEV)|iCAD - Balans kapitallashuviga qarzlar|Ikena Oncology Inc. - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati NTBL (Notable Labs Inc.)|Viracta Therapeutics (VIRX) - Sof aktivlarga qarzlar|MOR - Qarzning balans qiymatiga nisbati|nayabiosciences.com (NAYA) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar AAPGV